News Releases | Insmed Incorporated

Month Year

Email Alerts

Mar 1, 2023

Insmed To Present at Two March Conferences

Read more
Feb 23, 2023

Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Read more
Feb 9, 2023

Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023

Read more
Feb 7, 2023

Insmed To Present at the SVB Securities Global Biopharma Conference

Read more
Feb 3, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Jan 20, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Jan 6, 2023

Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference

Read more
Jan 3, 2023

Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference

Read more
Dec 6, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Nov 30, 2022

Insmed To Present at the Nasdaq 47th Investor Conference

Read more
Nov 4, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Nov 1, 2022

Insmed To Present at Three November Conferences

Read more
Oct 27, 2022

Insmed Ranks No. 1 on Science's 2022 Top Biopharma Employers List

Read more
Oct 27, 2022

Insmed Reports Third Quarter 2022 Financial Results and Provides Business Update

Read more
Oct 19, 2022

Insmed Announces Strategic Financings Totaling $775 Million

Read more
Oct 13, 2022

Insmed to Host Third Quarter 2022 Financial Results Conference Call on Thursday, October 27, 2022

Read more
Oct 7, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Oct 6, 2022

Insmed Holds Inaugural Global Day of Good - A Company-Wide Day of Service

Read more
Sep 7, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Sep 6, 2022

Insmed To Present at Two September Conferences

Read more
Aug 5, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Aug 4, 2022

Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update

Read more
Jul 21, 2022

Insmed to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022

Read more
Jul 8, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more
Jun 3, 2022

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation

Download

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Press Releases

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Footer